12:00 AM
 | 
Dec 21, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Multimeric-001 Universal Flu Vaccine: Phase I/II data

Data from a single-blind, placebo-controlled, dose-escalation, Israeli Phase I/II trial in 60 healthy volunteers ages 18-49 showed that 2 intramuscular injections of either low- or high-dose Multimeric-001 with or without adjuvant stimulated both antibody and cellular responses against several...

Read the full 172 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >